Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Communicable Diseases » Blood-Borne Infections » Hepatitis B
Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Hepadnaviridae Infections » Hepatitis B
Diseases [C] » Infections [C01] » Virus Diseases » Hepatitis, Viral, Human » Hepatitis B
Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Viral, Human » Hepatitis B
Description
INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. MeSH
Hierarchy View
Subtype Terms (1)
Hepatitis B, Chronic
164 drugs (46 approved, 118 experimental)
Phase 4 Indicated Drugs (34)
haemophilus influenzae type b conjugate vaccine (HibTITER)
hepatitis a vaccine, inactivated (vaqta)
hepatitis-a virus (inactivated) / hepatitis-b surface antigen (twinrix)
hepatitis b immune globulin (human) (BayHep B)
Phase 3 Indicated Drugs (34)
acellular pertussis vaccine (ACEL-IMUNE\T)
Bivalent group A and C meningococcal vaccine (Menomune-A/C)
bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV)
glyco-conjugate neisseria meningitidis serogroup c vaccine
Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant) (Comvax)
human rotavirus, live attenuated (Rotarix)
inactivated poliovirus type 2 vaccine
measles, mumps, rubella, varicella vaccine (ProQuad)
meningococcal conjugate vaccine (Menveo)
Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi)
phosphorothiolate oligodeoxyribonucleotide
Phase 2 Indicated Drugs (37)
Phase 1 Indicated Drugs (28)
Other Experimental Indicated Drugs (27)
Organization Involved with Phase 4 Indications (231)
Alaska Native Tribal Health Consortium
Asian Institute Of Medical Sciences
Asian-Pacific Alliance of Liver Disease, Beijing
Baqiyatallah Medical Sciences University
Beijing Kawin Technology Share-Holding Co., Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Case Western Reserve University
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention, China
Centre for Infectious Disease Research in Zambia (CIDRZ)
Children's National Medical Center
China Academy of Chinese Medical Sciences
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Daewoong Pharmaceutical Co. LTD.
Dalin Tzu Chi General Hospital
Department of Health, United Kingdom
Fifth Hospital of Shijiazhuang City
French National Agency for Research on AIDS and Viral Hepatitis
Fujian Cosunter Pharmaceutical Co. Ltd
Gottfried Wilhelm Leibniz Universität Hannover
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Hannover Clinical Trial Center GmbH
Hepatobiliary Disease Hospital of Jilin Province, Jilin, China
HIV-NAT Thai Red Cross AIDS Research Center
Huai'an No. 4 People's Hospital
Huazhong University of Science and Technology
Hubei University of Chinese Medicine
Huizhou People's Central Hospital
Humanity & Health Research Centre
Icahn School of Medicine at Mount Sinai
Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL)
International Antiviral Therapy Evaluation Center (IATEC)
Major Science and Technology Special Project of China Twelfth-Five-Year Project
Nanyang Technological University
National Cheng Kung University
National Health and Family Planning Commission, P.R.China
National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National University of Singapore
People's Liberation Army of China
Pontificia Universidad Catolica de Chile
Qingdao Infectious Diseases Hospital
Second Military Medical University
Shandong University of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Shenzhen Kangtai Biological Products Co., LTD
Shenzhen Third People's Hospital
Shineway Pharmaceutical Co.,Ltd
St. Martin De Porress Hospital
Taichung Veterans General Hospital
Taipei Veteran General hospital
The American Society of Tropical Medicine and Hygiene
The Fifth Hospital of Shijiazhuang
The Fifth People's Hospital of Suzhou
The Third Hospital of Qinhuangdao City
The Third People's Hospital of Taiyuan
Tung's Taiching MetroHarbor Hospital
University of British Columbia
University of California, San Diego
University of California, San Francisco
University of North Carolina at Chapel Hill
Yung Shin Pharm. Ind. Co., Ltd.
Organization Involved with Phase 3 Indications (68)
Advanced Medical Services GmbH
Bangabandhu Sheikh Mujib Medical University
Clinical Research Organization, Dhaka, Bangladesh
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization Involved with Phase 2 Indications (107)
A2 Healthcare Taiwan Corporation
Ascletis Pharmaceuticals Co., Ltd.
Australian Respiratory and Sleep Medicine Institute
Beijing Clinical Service Center
Centers for Disease Control and Prevention, Division of Reproductive Health
Gruppo Italiano Malattie EMatologiche dell'Adulto
Guangzhou Baidi Biotechnology Co., Ltd
Guangzhou Pharmaceucal Company Limited
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Huntington Medical Research Institutes
Lymphoma Disease Committee of TCOG
Metropolitan Liver Diseases/ Gastroenterology Center
National Center for Global Health and Medicine
Pharmaceutical Research Associates, Inc. (PRA)
Second People's Hospital of Yunnan Province
Shanghai HEP Pharmaceatical Co., Ltd.
Spring Bank Pharmaceuticals, Inc.
State University of Medicine and Pharmacy, Moldova
The HIV Netherlands Australia Thailand Research Collaboration
Tokyo Metropolitan Komagome Hospital
Universidad Autonoma de Barcelona
University of Alabama, Birmingham
University of California, Los Angeles
University of Roma La Sapienza
University of Texas, San Antonio
Virginia Commonwealth University
Organization Involved with Phase 1 Indications (33)
Organization Involved with Other Experimental Indications (44)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
